Total Funding
52
57
Total FundingSeries B raised
Growth Score
-5 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
43116
Elion Therapeutics is a cutting-edge biotechnology business focused on treating life-threatening IFIs
- Michelle Howard-Sparks: Senior Vice President of Product DevelopmentPast Role: EyePoint Pharmaceuticals, Vice President of Product Development
- Marty Burke: Founder
About the Company
Elion Therapeutics is a cutting-edge biotechnology business focused on treating life-threatening IFIs. Elion was built on the notion that mechanistic insights allow for focused optimization of natural goods.
